Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 6/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | FUCA1 | P04066 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 6/20 | 0.33 |
| ▸ | GBA1 | P04062 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28145005 | 1.00 | CA2 (0.42) | CA2CA9CA12FUCA1SMN1; SMN2 | |
| SCHEMBL3712080 | 1.00 | CA2 (0.42) | CA2CA9CA12FUCA1SMN1; SMN2 | |
| SCHEMBL3712541 | 1.00 | CA2 (0.42) | CA2CA9CA12FUCA1SMN1; SMN2 | |
| SCHEMBL2377987 | 1.00 | CA2 (0.42) | CA2CA9CA12FUCA1SMN1; SMN2 | |
| SCHEMBL2504504 | 1.00 | CA2 (0.42) | CA2CA9CA12FUCA1SMN1; SMN2 | |
| SCHEMBL81581 | 1.00 | CA2 (0.42) | CA2CA9CA12FUCA1SMN1; SMN2 | |
| SCHEMBL23541364 | 0.78 | FUCA1 (0.48) | CA2CA9CA12FUCA1SMN1; SMN2 | |
| SCHEMBL12556709 | 0.78 | FUCA1 (0.48) | CA2CA9CA12FUCA1SMN1; SMN2 | |
| SCHEMBL11962132 | 0.78 | FUCA1 (0.48) | CA2CA9CA12FUCA1SMN1; SMN2 | |
| SCHEMBL22923476 | 0.78 | FUCA1 (0.48) | CA2CA9CA12FUCA1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 201 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117486962-A | Ginsenoside derivative and preparation method and application thereof | 重庆市畜牧科学院 | 2024-02-02 | — | — | CN | claimed |
| CN-112204020-B | Dioxetane compounds and their use for detecting microorganisms | 尼米斯技术公司 | 2023-11-14 | — | — | CN | claimed |
| US-20230250123-A1 | GUT MICROBIOTA BIOACTIVATED PDE4 INHIBITOR PRECURSORS | GIIANT PHARMA INC. (CA) | 2023-08-10 | — | — | US | claimed |
| CN-113121619-B | Method for catalyzing phenol hydroxyl glycosylation by using organic thiourea | 江西师范大学 | 2023-06-09 | — | — | CN | claimed |
| US-11649475-B2 | Dioxetane compounds and their use for the detection of microorganisms | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2023-05-16 | — | — | US | claimed |
| CN-116056713-A | Intestinal microbiota bioactive PDE4 inhibitor precursors | 吉安特制药公司 | 2023-05-02 | — | — | CN | claimed |
| EP-4157853-A1 | GUT MICROBIOTA BIOACTIVATED PDE4 INHIBITOR PRECURSORS | Giiant Pharma Inc. (CA) | 2023-04-05 | — | — | EP | claimed |
| US-20220390459-A1 | RAPID, HIGH-INTENSITY CHEMILUMINESCENT DIOXETANES | BECKMAN COULTER, INC. | 2022-12-08 | — | — | US | claimed |
| CN-114867716-A | Fast, high intensity chemiluminescent dioxetanes | 贝克曼库尔特有限公司 | 2022-08-05 | — | — | CN | claimed |
| CN-113024627-B | Dammarane type triterpenoid saponin compound and preparation method and application thereof | 中国科学院昆明植物研究所 | 2022-03-25 | — | — | CN | claimed |
| US-20020147317-A1 | Fluorogenic compounds and uses therefor | 3M INNOVATIVE PROPETIES COMPANY | 2002-10-10 | — | — | US | claimed |
| EP-1204671-A1 | FLUOROGENIC COMPOUNDS AND USES THEREFOR | 3M Innovative Properties Company (US) | 2002-05-15 | — | — | EP | claimed |
| US-6372895-B1 | USEFUL IN ASSAYING FOR BIOLOGICAL ACTIVITY | 3M INNOVATIVE PROPERTIES COMPANY | 2002-04-16 | — | — | US | claimed |
| WO-2001029756-A2 | AUTOGRID ANALYSIS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2001-04-26 | — | — | WO | claimed |
| WO-2001010881-A1 | FLUOROGENIC COMPOUNDS AND USES THEREFOR | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2001-02-15 | — | — | WO | claimed |
| EP-0597915-B1 | A PROCESS FOR MAKING MORPHINE-6-GLUCURONIDE OR SUBSTITUTED MORPHINE-6-GLUCURONIDE | SALFORD ULTRAFINE CHEM & RES (GB) | 1998-11-11 | — | — | EP | claimed |
| US-5633261-A | ANTITUMOR AGENTS | TORONTO RESEARCH CHEMICALS, INC. (CA) | 1997-05-27 | — | — | US | claimed |
| US-5621087-A | ANALGESICS | SALFORD ULTRAFINE CHEMICALS AND RESEARCH LIMITED (GB) | 1997-04-15 | — | — | US | claimed |
| EP-0613478-A1 | IMMUNOSTIMULATING SWAINSONINE ANALOGS | TORONTO RESEARCH CHEMICALS INC. (CA) | 1994-09-07 | — | — | EP | claimed |
| WO-1993009117-A1 | IMMUNOSTIMULATING SWAINSONINE ANALOGS | TORONTO RESEARCH CHEMICALS INC. (CA) | 1993-05-13 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020147317-A1 | Fluorogenic compounds and uses therefor | NOTUM, WEE1, CPSF7 | CA2 4021/4885CA9 4264/4885CA12 3131/4885 |
| US-11649475-B2 | Dioxetane compounds and their use for the detection of microorganisms | DAXX, LITAF, EDF1 | CA2 2934/4885CA9 446/4885CA12 520/4885 |
| US-20230250123-A1 | GUT MICROBIOTA BIOACTIVATED PDE4 INHIBITOR PRECURSORS | PDE4A, PDE4B, PDE4C | CA2 1223/4885CA9 494/4885CA12 1776/4885 |
| US-20220390459-A1 | RAPID, HIGH-INTENSITY CHEMILUMINESCENT DIOXETANES | DAXX, DDX41, PDE8B | CA2 1412/4885CA9 220/4885CA12 81/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.